Inhibition of NF-κB Activity by Thalidomide through Suppression of IκB Kinase Activity
Top Cited Papers
Open Access
- 1 June 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (25), 22382-22387
- https://doi.org/10.1074/jbc.m100938200
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Thalidomide Inhibits Angiogenesis in Embryoid Bodies by the Generation of Hydroxyl RadicalsThe American Journal of Pathology, 2000
- How NF-κB is activated: the role of the IκB kinase (IKK) complexOncogene, 1999
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- Multiple signals converging on NF-κBCurrent Opinion in Cell Biology, 1999
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Signal transduction through NF-κBImmunology Today, 1998
- Thalidomide: lack of mutagenic activity across phyla and genetic endpointsMutation Research, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- ThalidomideDrug Safety, 1995
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994